About
A steady increase in the prevalence of allergic diseases globally has occurred with about 30-40% of the world population now being affected by one or more allergic conditions. Modern healthcare bodies and authorities agree that they cannot cure an allergy, but can only treat the symptoms by either avoiding the allergen, taking medications (Antihistamines and Steroids, epinephrine (EpiPen)), or getting into a long-lasting treatment process of 2-4 years, called Immunotherapy. We are developing a digital personalized healthcare therapy that will revolutionize the global allergy industry and the a/m concept by offering a nonintrusive solution that leverages decades of impactful alternative medicine therapies and techniques to overcome allergies. Our solution utilizes advanced algorithms that analyze patients' physiological parameters to autonomously administer a proprietary therapeutic protocol that by accessing the subconscious mind retrains the immune system to avoid, or reduce, allergy inflammation for a long period, which means developing resilience to the disease and prevent allergy symptoms for an extended period. Our methodology is firmly rooted in the modern holistic healthcare paradigm, which seamlessly integrates conventional medicine with complementary and alternative practices. The treatment, a quick 20- to 30-minute session, can be seamlessly integrated into mainstream healthcare or employed as a standalone therapy. Drawing inspiration from the scientific field of psychoneuroimmunology, our treatments address each patient's mental state and mindset. Pimea AI is committed to ushering in a new era of allergy relief that prioritizes individual well-being and long-term health.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Pimea AI's primary focus in healthcare?
- Pimea AI is developing a personalized digital healthcare therapy for allergies, aiming to retrain the immune system to reduce or avoid allergy inflammation.
- When was Pimea AI founded?
- Pimea AI was founded in June 2022.
- Where is Pimea AI headquartered?
- Pimea AI is headquartered in Tel Aviv-Yafo, Israel.
- What is the current funding stage of Pimea AI?
- Pimea AI is currently in the Pre-Funding stage.
- How many employees does Pimea AI have?
- Pimea AI has 3 employees.
- What technology does Pimea AI utilize in its solution?
- Pimea AI utilizes advanced algorithms, sensing technology, platforms & interfaces, and artificial intelligence to analyze physiological parameters and administer therapeutic protocols.
- What is the duration of Pimea AI's treatment session?
- Pimea AI's treatment session is a quick 20- to 30-minute session.
- Does Pimea AI hold any patents?
- Yes, Pimea AI holds one patent.
- Who is the founder of Pimea AI?
- Omer Hevlin is the founder of Pimea AI.